FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition according to invention contains (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or a pharmaceutically acceptable salt thereof in combination with olmesartan or a salt thereof or olmesartan medoxomil or a salt thereof.
EFFECT: use of inventions allows to significantly reduce the concentration of triglycerides and to increase HDL-cholesterol in blood due to the synergistic effect of the combination.
11 cl, 5 tbl, 2 ex
